FDA approves hydroxychloroquine as emergency coronavirus treatment

The 'known and potential' benefits outweigh the 'known and potential risks', says the regulator

The US drugs regulator has controversially approved the anti-malarial drugs hydroxychloroquine and chloroquine to treat seriously ill patients with COVID-19.


The emergency approval for use of the older-generation drugs in hospitals was granted by the FDA over the weekend, despite concern over a lack of safety or efficacy data for this indication.

In a letter granting approval for healthcare workers to administer oral formulations of the drugs for the treatment of COVID-19 in adolescents